Harvard Business Review: How Pharma Can Fix Its Reputation and Its Business at the Same Time
Damiano de Felice, deputy director of strategy at the Access to Medicine Foundation, discusses how research-based pharmaceutical companies can improve their return on investments and improve their reputations by “transform[ing] ‘access to medicine’ from a relentless activist slogan to a fully-fledged business strategy.” He writes, “[P]harma companies should develop innovative treatments for pervasive unmet medical needs; avoid corruption, collusion, and other unethical marketing practices; and make sure that their products reach as many patients around the world as possible…” (2/3).